title: Chemotherapy with doxorubicin, etoposide and cyclophosphamide (DEC) in ovarian cancer persistent after platinum-based treatment.
authors.forename: G
authors.initials: G
authors.lastname: Zanetta
authors.forename: S L
authors.initials: SL
authors.lastname: Monico
authors.forename: A
authors.initials: A
authors.lastname: Gabriele
authors.forename: D
authors.initials: D
authors.lastname: Miceli
authors.forename: C
authors.initials: C
authors.lastname: Mangioni
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide